Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare Conference

Rhea-AI Summary

Kala Pharmaceuticals (NASDAQ: KALA) will present at the Jefferies 2021 Virtual Healthcare Conference. The management team is scheduled for a fireside chat on June 3, 2021, at 10:00 am ET. Investors can access the live webcast and the archived recording through the Events section of the Kala website.

Kala focuses on innovative therapies for eye diseases, utilizing its AMPPLIFY® technology. Key products include EYSUVIS® for dry eye treatment and INVELTYS® for post-operative inflammation. The company also has a pipeline targeting unmet medical needs in ocular health.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies 2021 Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, June 3, 2021 at 10:00 am ET.

To access the webcast and subsequent archived recording of the presentation, please visit “Events” in the “Investors” section of the Kala website at http://kalarx.com

About Kala Pharmaceuticals, Inc.
Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY^® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS^® (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS^® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery. The Company also has a pipeline of preclinical development programs targeted to address unmet medical needs, including both front and back of the eye diseases. For more information on Kala, please visit www.kalarx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005206/en/

FAQ

When is Kala Pharmaceuticals presenting at the Jefferies 2021 Virtual Healthcare Conference?

Kala Pharmaceuticals will present on June 3, 2021, at 10:00 am ET.

Where can I access the webcast of Kala Pharmaceuticals' presentation?

The webcast can be accessed in the Events section of the Kala website.

What technologies does Kala Pharmaceuticals use for drug delivery?

Kala uses its AMPPLIFY® mucus-penetrating particle technology for its ocular therapies.

What are the primary products of Kala Pharmaceuticals?

Kala's main products include EYSUVIS® for dry eye disease and INVELTYS® for post-operative inflammation.

What is the focus of Kala Pharmaceuticals?

Kala Pharmaceuticals specializes in therapies for diseases of the eye.